This study compared and analyzed data from 13 different antibiotic treatment regimens which have been tried for Crohn's patients. They found a couple of antibiotics to be effective:
Their conclusions:Three trials of nitroimidazoles (206 patients) showed a significant benefit (odds ratio, 3.54), the researchers note, as did 4 trials of clofazimine (322 patients; OR, 2.86).
OK, look at what they found to be effective:"We believe that further research is justified to better define the role of antibacterial agents and combination regimens in Crohn's disease," the investigators say. "Future studies should focus on clofazimine, alone or in combination with a macrolide and a rifamycin, as well as in combination with a nitroimidazole, and perhaps ciprofloxacin."
nitroimidazoles - this class of antibiotics has been found to be especially effective against the three most medically important anaerobic protozoan parasites, Giardia, Trichomonas, and Entamoeba.
clofazimine - this is a fat-soluble riminophenazine dye, used in combination with rifampicin and dapsone, as multidrug therapy (MDT) for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients and Mycobacterium avium paratuberculosis infection in Crohn's disease patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum (ENL).
Note that certain macrolide antibiotics have been shown to be effective against mycobacteria, and ciprofloxacin is a broad-spectrum antibiotic that we on this board have found to be consistently effective for bringing temporary remission from the diarrhea associated with MC.
So, there seems to be some interest in pursuing the treatment of Crohn's disease, from the aspect of possible MAP involvement. How about that?
http://www.medscape.com/viewarticle/716394
Tex